Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypofractionated RT with Chemo and Consolidation Immunotherapy in LA-NSCLC
NCT04951063Phase 1Completed
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2021
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial in non-small cell lung cancer (NSCLC), sponsored by Sun Yat-sen University. Started Jun 2021; status: completed.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04951063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04951063.